Ethical Use of Antiretroviral Resources for HIV Prevention in Resource Poor Settings

作者: Stuart Rennie

DOI: 10.1111/DEWB.12022

关键词:

摘要: The effectiveness of antiretroviral regimes (ARVs) to reduce risk HIV transmission from mother child and as post-exposure prophylaxis has been known for almost two decades. Recent research indicates ARVs can also the via sexual intercourse in other ways. With pre-exposure (PrEP), are used acquisition among persons who negative significantly exposed virus. treatment prevention (TasP), already positive. development these new strategies raises a rationing problem: given chronic shortage HIV-infected need treatment, is it ethically justified allocate PrEP and/or TasP? This article examines intuitively appealing view that allocation should be highest priority, use TasP secondary utilizing would unethical. I will argue selective, evidence-based certain cases could even when there insufficient anti-retroviral access all those needing treatment.

参考文章(24)
Eleanor Gouws, John Hargrove, Brian G. Williams, Cari van Schalkwyk, Hilmarie Brand, Pre-exposure prophylaxis (PrEP) versus treatment-as-prevention (TasP) for the control of HIV: Where does the balance lie? arXiv: Populations and Evolution. ,(2012)
R. Ashcroft, Fair Process and the Redundancy of Bioethics: A Polemic Public Health Ethics. ,vol. 1, pp. 3- 9 ,(2008) , 10.1093/PHE/PHN004
Michael M Cassell, Daniel T Halperin, James D Shelton, David Stanton, Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ. ,vol. 332, pp. 605- 607 ,(2006) , 10.1136/BMJ.332.7541.605
Robert Hecht, Lori Bollinger, John Stover, William McGreevey, Farzana Muhib, Callisto Emas Madavo, David de Ferranti, Critical Choices In Financing The Response To The Global HIV/AIDS Pandemic Health Affairs. ,vol. 28, pp. 1591- 1605 ,(2009) , 10.1377/HLTHAFF.28.6.1591
Vinh-Kim Nguyen, Nathalie Bajos, Françoise Dubois-Arber, Jeffrey OʼMalley, Catherine M Pirkle, Remedicalizing an epidemic: from HIV treatment as prevention to HIV treatment is prevention. AIDS. ,vol. 25, pp. 291- 293 ,(2011) , 10.1097/QAD.0B013E3283402C3E
Lynn A Paxton, Tony Hope, Harold W Jaffe, Pre-exposure prophylaxis for HIV infection: what if it works? The Lancet. ,vol. 370, pp. 89- 93 ,(2007) , 10.1016/S0140-6736(07)61053-8
Myron S. Cohen, Kathryn E. Muessig, M. Kumi Smith, Kimberly A. Powers, Angela D.M. Kashuba, Antiviral agents and HIV prevention AIDS. ,vol. 26, pp. 1585- 1598 ,(2012) , 10.1097/QAD.0B013E3283543E83
A. Kagee, R.H. Remien, A. Berkman, S. Hoffman, L. Campos, L. Swartz, Structural barriers to ART adherence in Southern Africa: Challenges and potential ways forward Global Public Health. ,vol. 6, pp. 83- 97 ,(2011) , 10.1080/17441691003796387